Sydney E. Schultz, PharmD, @SydneyPharmD identifies presentation, prognostic factors and pathology associated with cancer of unknown primary, reviews historical treatment approaches, and discusses the role for use of molecular profiling to guide treatment. 

Twitter: @SydneyPharmD

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.